MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Rigidity"

  • 2018 International Congress

    Quantitative assessment of the hand motor symptoms in Parkinson’s disease based on a custom wearable device: A Proof-of-Principle Study

    Q. Ye, Z. Lin, H. Dai, Y. Xiong, G. Cai (Jinjiang, China)

    Objective: The objective of this study was to evaluate the feasibility of a wrist-worn wearable device to assist with the quantitative assessment of hand motor…
  • 2017 International Congress

    Do motor symptoms influence on malnutrition in Parkinson`s disease patients?

    S. Tomic, V. Pekic, Z. Popijac, T. Pucic, M. Petek, T. Gilman Kuric (Osijek, Croatia)

    Objective: The aim of this study was to determine the prevalence of malnutrition and to analyze influence of age, sex, disease duration and motor symptoms…
  • 2017 International Congress

    The FDA is listening: Integrating the voice of the patient in drug development for Parkinson’s and Huntington’s diseases.

    D. Stephenson, A. Porter, K. Romero, G. Podskalny, E. Bastings, B. Dunn, S. Goldstein, T. Mullin (Tucson, AZ, USA)

    Objective: To present highlights from the Patient-Focused Drug Development (PFDD) meetings held at FDA for Parkinson’s disease (PD) and Huntington’s disease (HD) to raise awareness…
  • 2017 International Congress

    Increased and symmetric expression of rigidity in early Parkinson’s disease with abnormal REM sleep without atonia

    M. Petrucci, S. Amundsen Huffmaster, C. Lu, P. Tuite, M. Howell, C. MacKinnon (Minneapolis, MN, USA)

    Objective: The purpose of this study was to compare the level and bilateral expression of upper arm rigidity between people with early stage Parkinson’s disease…
  • 2017 International Congress

    Assessing Parkinson’s disease motor symptoms using supervised learning algorithms

    P. Angeles, Y. Tai, N. Pavese, R. Vaidyanathan (London, United Kingdom)

    Objective: Implantable brain stimulators are now an established method of treating Parkinson’s Disease (PD). Determination of optimal neural stimulation parameters is complex and clinically demanding. The goal of…
  • 2017 International Congress

    Objective biomarkers of posture balance for early and advanced Parkinson’s disease

    I. Miliukhina, E. Gracheva, A. Kudrevatykh, T. Sergeev, M. Didur (Saint-Petersburg, Russian Federation)

    Objective: The aim of this study was to investigate the postural performance of patients with early and advanced Parkinson's disease (PD) using computerized posturography. Background:…
  • 2016 International Congress

    Quantification of tremor and rigidity during deep brain stimulation surgery for Parkison’s disease

    P. Poortvliet, A. Fytagoridis, T. Coyne, P. Silburn (Brisbane, Australia)

    Objective: The aim of this study is to validate practical and objective measures to assess changes in rigidity and tremor due to micro-lesion effects and…
  • 2016 International Congress

    Motor rigidity selectively associates with impaired odor identification in Parkinson’s disease

    J.D. Haugen, M.L.T.M. Muller, V. Kotagal, K.A. Frey, R.L. Albin, N.I. Bohnen (Ann Arbor, MI, USA)

    Objective: To investigate the relationship between impairments of the cardinal motor symptoms and odor identification deficits in Parkinson's disease (PD). Background: Although hyposmia has been…
  • 2016 International Congress

    Clinical and MRI-characteristics of drug-induced parkinsonism in Uzbekistan

    A. Umarov, A. Prokhorova, G. Rakhimbaeva, K. Mirzaeva, N. Tuychibaeva (Tashkent, Uzbekistan)

    Objective: To establish clinical and MRI morphometric differences between Parkinson's disease (PD) and Drug-induced parkinsonism (DP). Background: DP – is the most known side effect…
  • 2016 International Congress

    Influence of motor manifestation and onset’s side on the spectrum of non-motor symptoms in patients with Parkinson’s disease

    M.A. Nikitina, I.A. Zhukova, V.M. Alifirova, N.G. Zhukova, O.P. Izhboldina, J.S. Mironova, M.A. Titova, N.G. Brazovskaya (Tomsk, Russia)

    Objective: To analyze Parkinson's disease (PD) motor manifestation and onset's side influence on the spectrum of non-motor symptoms (NMS). Background: Possibly the onset's side and…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley